Is there a correlation between the release of interleukin-12 and the clinical outcome of polytrauma patients?

被引:0
作者
Wick, M [1 ]
Kollig, E [1 ]
Walz, M [1 ]
Muhr, G [1 ]
Köller, M [1 ]
机构
[1] Ruhr Univ Bochum, Chirurg Klin & Poliklin, Berufsgenossenschaftliche Kliniken Bergmannsheil, D-44789 Bochum, Germany
来源
CHIRURG | 2000年 / 71卷 / 09期
关键词
interleukin-12; polytrauma; thoraxtrauma; immune regulation;
D O I
10.1007/s001040051189
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Interleukin-12-p70 (IL-12-p70) is a potent immunoregulatory cytokine composed of a heavy chain (p40) and a light chain (p35). Contradicting results have been reported with regard to leukocyte release and systemic concentration of IL-12 after polytrauma. Methods: We daily analyzed systemic concentrations of IL-12 in polytrauma patients (n = 37, mean ISS 33.9) in comparison to healthy donor values during intensive carl course by ELISA. Patients were divided according to their mean IL-12 levels into those with elevated IL-12 (group 1, n = 7), those with decreased IL 12 (group 21 n = 4) and those with IL-12 in the normal range (group 3, n = 26). Results: Patients in group 1 revealed elevated levels of IL-12 up to p70 > 1000 pg/ml and p40 > 2500 pg/ml. The common clinical feature of group I was a thorax trauma in combination with pneumonia (85 % survivors). Patients with single thorax trauma or pneumonia without thorax trauma (group 3) showed normal IL-12 values. Patients with decreased IL-12 levels revealed also a thorax trauma and pneumonia but all patients succumbed. The groups significantly differ in their stay in the intensive care unit, in TISS, in MODS score and in respiratory ratio, but not in ISS, mean CRP values and leukocyte counts. Correlation analysis revealed no significant relation between systemically altered IL-12 values and clinical parameters, with the exception of a negative correlation of p70 and ISS (r = -0.785) or MODS score (r = -0.314) in group 1. Conclusions: After major injuries there is no overall suppression of IL-12 formation. Patients with normal or elevated IL-12 levels belong mainly to the survivors, whereas patients with decreased IL-12 levels are at high risk of succumbing to multi-organ failure.
引用
收藏
页码:1126 / 1131
页数:6
相关论文
共 28 条
  • [1] RISK-FACTORS FOR EARLY-ONSET PNEUMONIA IN TRAUMA PATIENTS
    ANTONELLI, M
    MORO, ML
    CAPELLI, O
    DEBLASI, RA
    DERRICO, RR
    CONTI, G
    BUFI, M
    GASPARETTO, A
    [J]. CHEST, 1994, 105 (01) : 224 - 228
  • [2] INJURY SEVERITY SCORE - METHOD FOR DESCRIBING PATIENTS WITH MULTIPLE INJURIES AND EVALUATING EMERGENCY CARE
    BAKER, SP
    ONEILL, B
    HADDON, W
    LONG, WB
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1974, 14 (03): : 187 - 196
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Early activation of pulmonary nuclear factor κB and nuclear factor interleukin-6 in polymicrobial sepsis
    Browder, W
    Ha, TZ
    Li, CF
    Kalbfleisch, JH
    Ferguson, DA
    Williams, DL
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1999, 46 (04) : 590 - 596
  • [5] BRUNDA MJ, 1994, J LEUKOCYTE BIOL, V55, P280
  • [6] CAR BD, 1995, AM J PATHOL, V147, P1693
  • [7] EIDELMAN LA, 1995, INTENS CARE MED, V21, P269
  • [8] Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness
    Ertel, W
    Keel, M
    Neidhardt, R
    Steckholzer, U
    Kremer, JP
    Ungethuem, U
    Trentz, O
    [J]. BLOOD, 1997, 89 (05) : 1612 - 1620
  • [9] RELEASE OF ANTIINFLAMMATORY MEDIATORS AFTER MECHANICAL TRAUMA CORRELATES WITH SEVERITY OF INJURY AND CLINICAL OUTCOME
    ERTEL, W
    KEEL, M
    BONACCIO, M
    STECKHOLZER, U
    GALLATI, H
    KENNEY, JS
    TRENTZ, O
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1995, 39 (05) : 879 - 887
  • [10] GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109